Novel KIF5A variant in a patient with early-onset levodopa-responsive Parkinson’s syndrome

View at publisher
Authors: Boyana R Kuzmanova, Maria R Kuzmanova, Magdeldin Elgizouli, Benjamin Tatrai, Jens Carsten Möller
Cited by: 0
References: 9

Abstract

We present the case of a male in his mid-30s with a progressive complex neurological phenotype primarily characterised by levodopa-responsive parkinsonism with motor fluctuations as well as gait ataxia, peripheral neuropathy and finally also spastic paraplegia. Genetic analysis identified a novel heterozygous variant in the KIF5A gene: c.937G>A (p.Glu313Lys). This variant is genetically classified as likely pathogenic. Other pathogenic mutations in the KIF5A gene are associated with hereditary spastic paraplegia type 10, Charcot-Marie-Tooth disease type 2 and amyotrophic lateral sclerosis. We discuss the clinical, genetic and prognostic implications of this finding.

Fields of Study & Subjects

Parkinson's Disease Mechanisms and Treatments Hereditary Neurological Disorders Neurological disorders and treatments

Publication details

Journal / source
BMJ Case Reports
Volume
19
Issue
2
Pages
e267762–e267762
Publication date
1 February 2026
Language
EN